News
02-08-2018, 12:26 AM
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that results from a large 1,162 patient study of the Myriad myRisk Hereditary Cancer test will be featured during the poster presentation at the 2018 Genitourinary Cancer Symposium in San Francisco, Calif.
More... (https://www.news-medical.net/news/20180208/Myriade28099s-myRisk-Hereditary-Cancer-test-finds-inherited-gene-mutations-in-more-than-1225-of-prostate-cancer-patients.aspx)
More... (https://www.news-medical.net/news/20180208/Myriade28099s-myRisk-Hereditary-Cancer-test-finds-inherited-gene-mutations-in-more-than-1225-of-prostate-cancer-patients.aspx)